Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.01
(
0.81%
)
Bitcoin
68,097.44
(
0.38%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: DewDiligence post# 173747

Tuesday, 02/04/2014 6:32:25 PM

Tuesday, February 04, 2014 6:32:25 PM

Post# of 257269
The only unresolved puzzle IF (?) FDA/EMA approves 8/12-week regimens without RBV is how much GILD is going to price sofosbuvir/ledipasvir FDC relative to Sovaldi. If it prices 1/3 higher, 8-week FDC is close to same price as 12-week Sovaldi. It does make ABBV/ENTA 12-week regimen pricing trickier.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today